Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection

Gallay Laure, View ORCID ProfileTran Viet-Thi, Perrodeau Elodie, Vignier Nicolas, Mahevas Matthieu, Bisio Francesca, Forestier Emmanuel, Lescure Francois-Xavier on behalf of the COCO-OLD Study group
doi: https://doi.org/10.1101/2020.11.10.20226886
Gallay Laure
1Département de Médecine Interne et Immunologie Clinique, Centre Hospitalo-Universitaire Edouard Herriot, Hospices Civils de Lyon, Université Claude Bernard Lyon 1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tran Viet-Thi
2Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris / Université de Paris, Centre de Recherche Epidémiologie et Statistiques (CRESS UMR 1153)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tran Viet-Thi
Perrodeau Elodie
2Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris / Université de Paris, Centre de Recherche Epidémiologie et Statistiques (CRESS UMR 1153)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vignier Nicolas
3Groupe hospitalier Sud Ile-de-France, Inserm CIC 1424 & Sorbonne Université, IPLESP, Inserm UMR 1136, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahevas Matthieu
4Service de Médecine Interne, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, 75000 Paris France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bisio Francesca
5Département de Médecine, Centre Hospitalier de Vierzon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Forestier Emmanuel
6Service de Maladies Infectieuses, Centre Hospitalier Métropole Savoie, Chambéry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lescure Francois-Xavier
7Service de maladies infectieuses et tropicales, Hôpital Bichat, Assistance Publique Hôpitaux de Paris / Université de Paris, IAME, Inserm UMR 1137, 75018 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xavier.lescure@aphp.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To assess the effectiveness of corticosteroids among elderly patients with COVID-19 pneumonia requiring oxygen.

Design Comparative observational study based on routine care data. Baseline characteristics of patients were balanced using propensity-score inverse probability of treatment weighting.

Setting Geriatric and infectious diseases wards from 36 hospitals in France and Luxembourg.

Participants Adults > 80 years old PCR confirmed SARS-CoV-2 infection or typical CT-scan images, requiring oxygen ≥ 3L/min and with an inflammatory syndrome (C-reactive protein ≥ 40mg/L).

Measurements The primary outcome was overall survival at day 14. The secondary outcome was the proportion of patients discharged from hospital to home/rehabilitation on day 14. Adverse events were abstracted from electronic health records.

Results Among the 267 patients included in the analysis, 96 were assigned to the treatment group. Median age was 86, interquartile range 83 to 90 and 95% had a SARS-CoV-2 PCR-confirmed diagnosis. Use of corticosteroids was significantly associated with an increased survival (weighted hazard ratio [wHR] 0.66, 95% CI 0.44 to 0.97). There was no significant difference between the treatment and control groups regarding the proportion of patients discharged to home/rehabilitation at day 14 (wRR 1.11, 95% CI 0.68 to 1.81). Twenty-two (16.7%) patients receiving corticosteroids developed adverse events while only 11 (6.4%) from the control group did.

Conclusions Corticosteroids were associated with a significant increase the day-14 overall survival of patients over 80 years old hospitalized for severe COVID-19.

Impact statement We certify that this work is novel. As of today, studies on the efficacy of corticosteroids did not specifically target elderly patients.

Among older patients aged over 80 years old, the RECOVERY trial found no difference in the survival of patients treated or not with dexamethasone. However, the heterogeneity in the severity of infection within the latter subgroup limited the drawing of strong conclusions

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No specific funding was obtained for this work

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the IRB of the Henri Mondor Hospital (2020_060).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • COCO-OLD Study Group (file attached)

Data Availability

Data are available upon reasonable request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection
Gallay Laure, Tran Viet-Thi, Perrodeau Elodie, Vignier Nicolas, Mahevas Matthieu, Bisio Francesca, Forestier Emmanuel, Lescure Francois-Xavier
medRxiv 2020.11.10.20226886; doi: https://doi.org/10.1101/2020.11.10.20226886
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection
Gallay Laure, Tran Viet-Thi, Perrodeau Elodie, Vignier Nicolas, Mahevas Matthieu, Bisio Francesca, Forestier Emmanuel, Lescure Francois-Xavier
medRxiv 2020.11.10.20226886; doi: https://doi.org/10.1101/2020.11.10.20226886

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)